Preventive effect of droplets on infant's jaundice

Not Applicable

• Conditions: eonatal jaundice.; neonatal jaundice; p59.9

• Registration Number: IRCT2016060128188N1
• Lead Sponsor: Vice Chancellor for research of Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 444

Inclusion Criteria

Full-term baby (with gestational age 38-42 weeks)
Birth weight 2.5-4 kg
No postpartum complications
Breastfeeding within the hour of birth
Availability of parents for follow-up purposes
PO tolerance by the infant (no nausea, vomiting or obstructive symptoms
The absence of meconium contamination
No need for CPR at birth
No labor trauma

Exclusion Criteria

Genetic and congenital abnormalities or intrauterine infections
Jaundice within the first 24 hours of birth
ABO or Rh incompatibility
Presence of neonatal hemolytic process
Neonates with bleeding and cephalohematoma
Self-administration of Cotoneaster

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Added at 2017-06-11: Baby serum total bilirubin. Timepoint: Added at 2017-06-11: Every 24 hours for 3 days. Method of measurement: Added at 2017-06-11: Using a bilirubin test device (if a bilirubin is high, a bilirubin serum test will be performed based on the weight and age curve).

Secondary Outcome Measures

Name	Time	Method
Require hospitalization and Length of hospitalization days. Timepoint: From discharge to 14 days after birth. Method of measurement: Follow up by phone from the baby's parents.;Added at 2017-06-18: Evaluation of side effects in case of Cotoneaster. Timepoint: Added at 2017-06-18: Every 24 hours for 3 days. Method of measurement: Added at 2017-06-18: Observation and complete check list.